Dr. Reddy's Laboratories Ltd. (RDY)

38.79
0.32 0.82
NYSE : Health Technology
Prev Close 39.11
Open 38.45
Day Low/High 38.18 / 38.79
52 Wk Low/High 31.58 / 42.82
Volume 141.00K
Avg Volume 188.20K
Exchange NYSE
Shares Outstanding 166.06M
Market Cap 6.36B
EPS 1.60
P/E Ratio 23.30
Div & Yield 0.26 (0.69%)
Dr. Reddy's (RDY) Stock Gained Today on Earnings Beat

Dr. Reddy's (RDY) Stock Gained Today on Earnings Beat

Dr. Reddy's (RDY) shares were up today after the company reported third quarter results that beat analysts' guidance.

Dr. Reddy's Q3 And 9 Months FY15 Financial Results

Dr. Reddy's Q3 And 9 Months FY15 Financial Results

Dr. Reddy's Laboratories Ltd.

Dr. Reddy's To Release Q3 FY15 Results On January 29, 2015

Dr. Reddy's To Release Q3 FY15 Results On January 29, 2015

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third Quarter ended December 31, 2014 on Thursday, January 29, 2015 after the Board Meeting.

Dr. Reddy's Laboratories Closes The Acquisition Of Habitrol® Brand From Novartis

Dr. Reddy's Laboratories Closes The Acquisition Of Habitrol® Brand From Novartis

Dr. Reddy's Laboratories has announced that it has closed the acquisition of Habitrol® brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc.

Dr. Reddy's Announces The Launch Of Valganciclovir Tablets, USP

Dr. Reddy's Announces The Launch Of Valganciclovir Tablets, USP

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Valganciclovir Tablets USP 450 mg, a therapeutic equivalent generic version of VALCYTE ® (Valganciclovir) tablets in the US market on December...

Today Dr Reddy Laboratories (RDY) Hits New Lifetime High

Today Dr Reddy Laboratories (RDY) Hits New Lifetime High

Trade-Ideas LLC identified Dr Reddy Laboratories (RDY) as a new lifetime high candidate

Dr. Reddy's Announces The Launch Of Docetaxel Injection USP

Dr. Reddy's Announces The Launch Of Docetaxel Injection USP

Dr. Reddy's Laboratories (NYSE: RDY) announced today that is has launched Docetaxel Injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of TAXOTERE ® (docetaxel Injection) in the US...

Dr. Reddy's Announces The Launch Of Over-the-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets

Dr. Reddy's Announces The Launch Of Over-the-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched its over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg, a bioequivalent...

3 Drugs Stocks Pushing The Industry Higher

3 Drugs Stocks Pushing The Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Today Dr Reddy Laboratories (RDY) Hits New Lifetime High

Today Dr Reddy Laboratories (RDY) Hits New Lifetime High

Trade-Ideas LLC identified Dr Reddy Laboratories (RDY) as a new lifetime high candidate

Dr. Reddy's Q2 And H1 FY15 Financial Results

Dr. Reddy's Q2 And H1 FY15 Financial Results

Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Announces The Launch Of Sirolimus Tablets, 1 Mg And 2 Mg

Dr. Reddy's Announces The Launch Of Sirolimus Tablets, 1 Mg And 2 Mg

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Sirolimus Tablets 1 mg and 2 mg, a therapeutic equivalent generic version of RAPAMUNE ® (Sirolimus) tablets in the US market on October 27,...

Dr. Reddy's To Release Q2 FY15 Results On October 29, 2014

Dr. Reddy's To Release Q2 FY15 Results On October 29, 2014

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Second Quarter ended September 30, 2014 on Wednesday, October 29, 2014 after the Board Meeting.

New Lifetime High For Dr Reddy Laboratories (RDY)

New Lifetime High For Dr Reddy Laboratories (RDY)

Trade-Ideas LLC identified Dr Reddy Laboratories (RDY) as a new lifetime high candidate

Dr. Reddy’s Announces The Launch Of LEVALBUTEROL INHALATION SOLUTION, USP

Dr. Reddy’s Announces The Launch Of LEVALBUTEROL INHALATION SOLUTION, USP

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Levalbuterol Inhalation Solution, USP 0.

Trade-Ideas: Dr Reddy Laboratories (RDY) Is Today's New Lifetime High Stock

Trade-Ideas: Dr Reddy Laboratories (RDY) Is Today's New Lifetime High Stock

Trade-Ideas LLC identified Dr Reddy Laboratories (RDY) as a new lifetime high candidate

India Is Still Surging

The entire universe of Indian equities seems reasonably priced.

New Lifetime High For Dr Reddy Laboratories (RDY)

New Lifetime High For Dr Reddy Laboratories (RDY)

Trade-Ideas LLC identified Dr Reddy Laboratories (RDY) as a new lifetime high candidate

3 Stocks Dragging The Health Care Sector Downward

3 Stocks Dragging The Health Care Sector Downward

TheStreet highlights 3 stocks pushing the health care sector lower today.

Dr. Reddy’s Q1 FY15 Financial Results

Dr. Reddy’s Q1 FY15 Financial Results

Dr. Reddy’s Laboratories Ltd.

Dr. Reddy's To Release Q1 FY15 Results On July 30, 2014

Dr. Reddy's To Release Q1 FY15 Results On July 30, 2014

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2014 on Wednesday, July 30, 2014 after the Board Meeting.

Dr Reddy Laboratories Ltd Stock Upgraded (RDY)

Dr Reddy Laboratories Ltd Stock Upgraded (RDY)

Dr Reddy Laboratories (NYSE:RDY) has been upgraded by TheStreet Ratings from a hold to buy.

Ratings Changes Today

Upgrades: FFBC, GRT, GTS, QEP, RDY Downgrades: None Initiations: EPZM, FRBA, KMDA Read on to get TheStreet Quant Ratings' detailed report:

Dr. Reddy’s Laboratories Limited Announces Filing Of Annual Report On Form 20-F

Dr. Reddy’s Laboratories Limited Announces Filing Of Annual Report On Form 20-F

Dr. Reddy’s Laboratories Limited (NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2014 was filed with the ...

Dr. Reddy’s Announces The Launch Of Duloxetine Delayed-Release Capsules USP

Dr. Reddy’s Announces The Launch Of Duloxetine Delayed-Release Capsules USP

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Duloxetine Delayed-Release Capsules USP 20 mg, 30 mg and 60 mg, a therapeutic equivalent generic version of CYMBALTA ® (Duloxetine ...

Dr. Reddy’s Announces The Launch Of Paricalcitol Capsules

Dr. Reddy’s Announces The Launch Of Paricalcitol Capsules

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Paricalcitol Capsules, 1 mcg, 2 mcg and 4 mcg, a therapeutic equivalent generic version of ZEMPLAR ® (Paricalcitol) Capsules in the...

3 Stocks Raising The Drugs Industry Higher

3 Stocks Raising The Drugs Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Tread Carefully If Trying to Ride India's Rally

Tread Carefully If Trying to Ride India's Rally

Indian markets have rallied to record highs on the election of a new government pledging economic reform, but fund managers warn of pitfalls when investing in the world's second-most-populous nation.

Dr Reddy Laboratories Ltd Stock Downgraded (RDY)

Dr Reddy Laboratories Ltd Stock Downgraded (RDY)

Dr Reddy Laboratories (NYSE:RDY) has been downgraded by TheStreet Ratings from from a buy to hold.

3 Stocks Pushing The Health Care Sector Lower

3 Stocks Pushing The Health Care Sector Lower

TheStreet highlights 3 stocks pushing the Health Care sector lower today.

TheStreet Quant Rating: B- (Buy)